Peter Strothman has spent his career investing in the healthcare and private equity industries. He focuses on companies specializing in life sciences, specialty pharmaceutical products and services, and general healthcare products and services. Peter has built a leading group of pharmaceutical companies for Water Street and established an innovative corporate partnership program that supports the world’s leading healthcare companies with leveraging their investment in product-level R&D. Prior to Water Street, Peter was a principal with JLL Partners, where he focused exclusively on healthcare investments. He began his career in the Global Mergers and Acquisitions group of Lehman Brothers. Peter currently serves as a director of EVERSANA, Discovery Life Sciences, Cato-SMS Research, Capstone Development Solutions, Custopharm, Long Grove Pharmaceuticals and Viant. He is a former director of AAIPharma Services, Bioclinica and OraPharma. Peter received a bachelor’s degree in economics from Harvard University.